Browsing Tag
Stablepharma
5 posts
Stablepharma company profile: Business model, pipeline, and growth outlook (2026 edition)
Stablepharma is a UK biotech developing fridge-free vaccines and injectables via its StablevaX platform. Explore its Phase 1 pipeline, AFT Pharmaceuticals partnership, and 2026-2027 growth outlook.
No fridge, no problem: Stablepharma and AFT join forces to make critical drugs shelf-stable
Stablepharma and AFT team up to develop fridge-free cancer and infection drugs. Find out how this could reshape pharma logistics and global access.
Fridge-free vaccine milestone: Stablepharma locks Phase I SPVX02 data in thermostability push
Stablepharma has completed its first human trial for SPVX02, a fridge-free tetanus-diphtheria vaccine designed to work without cold-chain storage. With the data now locked, the company is preparing to scale its thermostable platform for global deployment.
Stablepharma’s fridge-free vaccine breakthrough: Dr Karen O’Hanlon explains the StablevaX journey
Find out how Stablepharma’s SPVX02 could redefine global vaccine logistics with fridge-free technology. Dr Karen O’Hanlon explains the science behind StablevaX™.
Game-changer in vaccines? Stablepharma’s fridge-free tech wins €2.5m boost!
UK-based biotechnology company Stablepharma Ltd has secured €2.5 million in funding from the prestigious European Innovation Council (EIC)…